Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →
Diagnostic lab revenue spans five channels — walk-in B2C, hospital B2B, corporate empanelment, online test aggregators, and home collection — each with a different rate card, settlement cycle, and tax overlay, and aggregator settlements routinely leak 1.0–2.0% to misclassified packages and uninvoiced add-ons.
Decompose each aggregator settlement file into booking-level lines, match every line to the LIMS booking by aggregator ref + test code, apply the contractual per-test lab-share rate, classify variances as package-vs-individual misclassification, courier add-on shortfall, convenience-fee absorption, or retroactive rate-card drift, and overlay GST exemption boundary plus TDS deductor reconciliation.
5 channel rate cards, 4+ aggregator platform formats, GST exemption test under Notification 12/2017, 18% GST on wellness/courier/home-collection convenience fees, TDS code 1002 for professional services on B2B referrer payments, pure-agent test for radiology sub-contracting.
Per-booking lab-share variance report, channel-wise revenue leakage quantum, TDS receivable register reconciled to 26AS by deductor, GST exempt vs taxable revenue split for GSTR-1, aggregator-wise dispute queue.
A diagnostic lab chain looks like a single business from the outside, but the revenue ledger is five businesses stitched together. Each channel — walk-in, hospital B2B, corporate empanelment, online aggregator, home collection — has its own rate card, settlement cycle, and tax treatment. The reconciliation problem is not “did the money arrive” but “did the right amount arrive for the right test under the right rate card, and was the tax overlay applied correctly”.
Quick Reference: Diagnostic Lab Revenue Channels
| Channel | Typical Share | Settlement Cycle | Rate Basis | Tax Overlay |
|---|---|---|---|---|
| Walk-in B2C | 30–40% | Same-day cash/UPI/card | Lab MRP | GST exempt (clinical) |
| Hospital B2B referral | 18–25% | 30–45 days | Negotiated B2B card | Section 194J TDS (code 1002) at 10% |
| Corporate empanelment | 12–18% | 30–60 days | Empanelment package | Section 194J TDS (code 1002) at 10% |
| Online test aggregator | 15–22% | 7–21 days | % share of MRP | Aggregator commission TDS; convenience fee 18% |
| Home-sample collection | 5–10% | Same-day / aggregator-linked | Lab MRP + convenience | Convenience fee 18% GST |
What Diagnostic Lab Revenue Reconciliation Covers
Diagnostic lab revenue reconciliation is the process of matching every booking in the laboratory information management system (LIMS) against the corresponding collection — cash, card, UPI, aggregator settlement, hospital remittance, or corporate invoice — and confirming that the amount collected matches the contractual rate for that test on that channel, net of legitimate deductions.
For a multi-channel lab chain, the LIMS is the single source of truth for tests performed. Every other system — the POS at the collection centre, the aggregator settlement file, the hospital remittance advice, the corporate billing system — is a downstream view of one slice of the revenue. The reconciliation job is to fan these slices back to LIMS bookings and quantify any gap.
How Aggregator Settlement Reconciliation Actually Works
Decomposing the Aggregator Share
A booking on a test aggregator splits into four components: the test MRP listed on the app, the aggregator’s discount or commission spread, a platform collection fee, and the net lab share. For a typical lipid profile listed at ₹900 MRP, a 45% lab-share contract pays ₹405 to the lab; the aggregator retains ₹495 covering its discount-to-customer, marketing margin, and platform overhead. If the customer also opts for home collection, a convenience fee — often ₹150–₹250 — is added to the customer’s bill, and the lab’s share of that fee depends on the contract.
The settlement file from the aggregator lists each booking by its platform reference, the MRP, the deductions applied, and the net payable. Reconciling the file requires matching each line to the LIMS booking using the aggregator reference and the test code, then applying the contractual lab-share rate to derive the expected payable, then comparing expected to actual.
Why the Bank Credit Alone Is Insufficient
A monthly aggregator settlement from a major platform might be ₹50–₹70 lakh credited as a single bank entry. The bank narration confirms the credit arrived. It does not confirm that the per-booking economics are correct. A package test — say, a “Full Body Checkup” with 60 parameters — that gets settled at individual-test lab shares instead of the negotiated package rate is silent leakage. Multiply that across 4,000 monthly bookings and the variance grows quickly.
Common Aggregator Leakage Patterns
Four patterns recur across aggregator settlements. Package tests booked at the customer-facing package MRP get reconciled at the individual-test rate sheet, which is materially lower than the package rate the lab negotiated. Courier charges for samples transported from a remote collection point to the central lab are absorbed by the lab when the contract said the aggregator would pass them through. Convenience fees collected from the customer for home collection are retained by the aggregator when the contract said the lab gets a 60% share. Rate-card revisions — for example, a new GST notification or a renegotiated commercial — take effect retroactively in the aggregator’s system but the lab’s billing reference card lags by a quarter.
Model aggregator-channel exception cost
Aggregator settlement variance on diagnostic lab tests routinely leaks 1.2-2.0% of channel revenue. Model the carrying cost across your aggregator mix.
Open the Exception Cost Calculator →A Worked ₹140 Cr Lab Chain Example
Consider a mid-sized diagnostic lab chain with ₹140 Cr annual revenue across 28 collection centres in three states. The channel mix is representative of the segment: walk-in B2C 38% (₹53.2 Cr), hospital B2B referral 22% (₹30.8 Cr), corporate empanelment 15% (₹21.0 Cr), online aggregator 18% (₹25.2 Cr), home-sample collection 7% (₹9.8 Cr).
The aggregator channel is the smallest share but the highest-friction reconciliation target. Across four platforms — Dr Lal PathLabs’ own marketplace arm, Thyrocare Beacon, PharmEasy, and Tata 1mg — the lab receives roughly ₹2.1 Cr per month in aggregator settlements. The bank credits arrive on schedule and tie to the platforms’ settlement summaries. The leakage shows up only when the settlement file is decomposed booking-by-booking and matched to the LIMS rate card.
In a representative month, the reconciliation surfaces three patterns. First, 312 package-test bookings were settled at the individual-test sum rather than the contractual package rate, generating a ₹6.4 lakh shortfall. Second, courier charges for 1,840 home-collection samples — contractually billable at ₹40 per pickup — were not invoiced back to one of the platforms, a ₹4.9 lakh leakage. Third, convenience fees collected from customers for home-collection upgrades were retained 100% by two aggregators despite a 60:40 contract, a ₹2.7 lakh leakage. Combined leakage for the month: roughly ₹14 lakh, or about 6.7% of the month’s aggregator revenue and just under 1% of total monthly revenue.
Annualised, the leakage is meaningful enough to justify a dedicated channel-level reconciliation rather than relying on the aggregator’s settlement summary at face value.
GST Exemption Boundary for Lab Services
The GST treatment of diagnostic lab revenue is governed by Notification 12/2017 — Central Tax (Rate), which exempts health-care services provided by a clinical establishment, an authorised medical practitioner, or paramedics. The exemption clearly covers diagnostic tests, pathology, radiology, and sample collection that is integral to a covered test.
The exemption boundary becomes important on three line items. Wellness packages — marketed as preventive lifestyle programmes that bundle tests with non-clinical add-ons — must be evaluated individually. A “Healthy Heart Package” that is a bundle of lipid profile, ECG, and TMT remains within the clinical exemption. A “Corporate Wellness Programme” that includes a clinical lab component plus nutrition counselling, fitness assessment, and lifestyle coaching is composite; the lab portion may stay exempt but the non-clinical wrap is taxable at 18%.
Courier charges billed separately for sample transport are not part of the diagnostic service when invoiced as a standalone line, and attract 18% GST. Home-collection convenience fees are similarly outside the exemption boundary when not embedded in the test price. Labs that bury both inside the test MRP keep the exemption intact; labs that break them out as visible line items create a partial-taxable revenue stream that must be tracked separately for GSTR-1.
For the ₹140 Cr lab chain above, the exempt-vs-taxable split typically lands at ₹133–₹135 Cr exempt clinical revenue and ₹5–₹7 Cr taxable revenue from wellness wraps, courier, and convenience fees. Misclassifying a wellness wrap as exempt invites a GST notice; misclassifying a clinical test as taxable inflates the customer’s bill and erodes channel competitiveness.
TDS Overlay: Section 194J and the 2026 Code
Hospitals and corporates that pay diagnostic labs for empanelment-based testing deduct TDS under Section 194J for professional or technical services at 10%. Under the TDS 2026 framework, the corresponding payment code reported by the deductor is 1002 — professional services. The lab’s reconciliation must tie every 26AS credit back to the corresponding deductor’s invoice, by quarter, and surface any deductor who has remitted tax to the government but not yet issued a Form 16A.
The aggregator commission flow runs in the opposite direction. When the aggregator deducts its commission from the lab’s gross MRP share, the aggregator is the recipient of professional service income from the lab. Many large aggregators ask the lab to gross up the commission and deduct TDS on the commission component. This creates a TDS payable on the lab’s side, reported under the appropriate section depending on the contractual treatment, and must be reconciled against the aggregator’s invoice for commission separately from the settlement reconciliation.
The radiology sub-contracting case adds a third TDS pattern. When the lab outsources MRI or CT scans to a partner imaging centre and pays the partner per scan, the lab deducts TDS under Section 194J on the partner’s invoice. If the lab has correctly applied the pure-agent treatment under Rule 33 of the CGST Rules, the reimbursement portion of the patient’s bill is excluded from the lab’s GST value of supply, while the TDS on the partner payment continues to apply.
Where Reconciliation Software Earns Its Keep
The structural pattern across all five channels — a batch settlement that hides booking-level economics — is the same problem reconciliation software India is built to address: fan a batch credit back to its underlying transactions, apply a rate-card or expected-amount model, and quantify the variance. The GST exempt-vs-taxable split surfaces the same way: per-line tax classification matched against the GSTR-1 output, exactly the workflow GST reconciliation software automates for multi-rate businesses.
The full text of the GST health-care services exemption sits in Notification 12/2017 published by CBIC GST, the Central Board of Indirect Taxes and Customs.
Continue Reading
For the adjacent revenue-cycle problems on the hospital and insurer side, see hospital billing reconciliation India for the in-patient and out-patient billing reconciliation pattern, TPA settlement reconciliation India for the batch-claim sidecar file pattern across 19+ TPAs, and cashless claim settlement reconciliation for the preauthorisation-to-settlement workflow that adjoins lab work for in-patient diagnostics.
The five most common questions about diagnostic lab revenue reconciliation in India are answered below.